Video

Dr Sachin Jain Previews Upcoming Discussion With Former HHS Secretary

Sachin Jain, MD, MBA, FACP, previews some of the topics of discussion for his talk with former HHS Secretary Kathleen Sebelius at the upcoming 2021 Health Datapalooza and National Health Policy Conference.

Sachin Jain, MD, MBA, FACP, is the president and CEO at SCAN Group and SCAN Health Plan.

Transcript:

Datapalooza will take place near the one-month mark of the Biden Administration, and your conversation with former HHS Secretary Kathleen Sebelius will discuss where we go next in healthcare reform. What do you see as “year one” tasks for the new administration, as well as “must do” items for a first term?

Jain: I couldn't be more excited about my upcoming conversation with Secretary Sebelius. I think that the "year one" task is to stabilize the country's COVID-19 response. I think there's many of us who are very interested in seeing progressive movement around innovative uses of data. We're very interested in expansions and coverage and new payment models. But ultimately, I think the moment requires that we all focus our energies and attention to improving our pandemic response. And so, I believe that some of the conversation with Secretary Sebelius will focus on her thoughts on how we could do better as a country in our response to the global pandemic.

Related Videos
Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine at USC
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Emma Achola-Kothari
Matthew Viggiano, MD, internal medicine resident, Temple University Hospital
Krunal Patel, MD, pulmonary and critical care fellow, Temple University Hospital
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill
Dr Margrit Wiesendanger
Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia
Michael Goulet, DO, pulmonary and critical care fellow, Temple University Hospital
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo